{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T09:56:25Z","timestamp":1694685385150},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T00:00:00Z","timestamp":1346284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00105-012-2377-0","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T05:19:54Z","timestamp":1346131194000},"page":"868-871","source":"Crossref","is-referenced-by-count":3,"title":["Candida glabrata"],"prefix":"10.1007","volume":"63","author":[{"given":"H.-J.","family":"Tietz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,30]]},"reference":[{"key":"2377_CR1","unstructured":"Ausschuss f\u00fcr biologische Arbeitsstoffe (2002) Einstufung von Pilzen in Risikogruppen (TRBA 460), Bundesarbeitsblatt 10"},{"key":"2377_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11046-008-9119-y","volume":"166","author":"Savini","year":"2008","unstructured":"Savini V, Catavitello C, Manna A et al (2008) Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies. Mycopathologia 166:47\u201350","journal-title":"Mycopathologia"},{"key":"2377_CR3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1703252","volume":"28","author":"Safdar","year":"2001","unstructured":"Safdar A, Rhee F van, Henslee-Downey JP et al (2001) Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant 28:873\u2013878","journal-title":"Bone Marrow Transplant"},{"key":"2377_CR4","unstructured":"Tietz HJ, Sterry W (2006) Antimykotika von A-Z, 4. Aufl. Thieme, Stuttgart"},{"key":"2377_CR5","unstructured":"Tietz HJ (2011) Antimykotika von A-Z, 5. Aufl. Ligatur, Stuttgart"},{"key":"2377_CR6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4236\/health.2010.26077","volume":"2","author":"Tietz","year":"2010","unstructured":"Tietz HJ (2010) Treatment of chronic vulvovaginal candidiasis with posaconazole and ciclopiroxolamine. Health 2:391\u2013394","journal-title":"Health"},{"key":"2377_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1368-5031.2004.00167.x","volume":"58","author":"Herbrecht","year":"2004","unstructured":"Herbrecht R (2004) Posaconazole: a potent, extended spectrum triazole antifungal for the treatment of serious fungal infections. Int J Clin Pract 58:612\u2013624","journal-title":"Int J Clin Pract"},{"key":"2377_CR8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.clinthera.2007.09.015","volume":"29","author":"Schiller","year":"2007","unstructured":"Schiller DS, Fung HB (2007) Posaconazole: an extended spectrum triazole antifungal agent. Clin Ther 29:862\u2013886","journal-title":"Clin Ther"},{"key":"2377_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tripleo.2007.12.003","volume":"105","author":"Oliveira","year":"2008","unstructured":"Oliveira ER, Fothergill A, Kirkpatrick WR et al (2008) Antifungal susceptibility testing of micafungin against Candida glabrata isolates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:457\u2013459","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2377-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-012-2377-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2377-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:57Z","timestamp":1558568277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-012-2377-0"}},"subtitle":["Pathogenit\u00e4t und Stand der Therapie"],"short-title":[],"issued":{"date-parts":[[2012,8,30]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1007\/s00105-012-2377-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,30]]}}}